Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
  1. 4 Planned sale EVP R&D, Chief Medical Officer sold 14,349 shares at $30.77 ($441,550)
  2. 4 Planned sale SVP, Chief Commercial Officer sold 5,208 shares at $29.15 ($151,813)
  3. 4 Planned sale EVP R&D, Chief Medical Officer sold 58,996 shares at $30.08 ($1,774,576)
  4. 4 Planned sale EVP R&D, Chief Medical Officer sold 10,471 shares at $29.53 ($309,169)
  5. 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 895 shares (to pay taxes)
  6. 4 Shares withheld for taxes Director gave up 1,465 shares (to pay taxes)
  7. 4 Shares withheld for taxes Director gave up 1,465 shares (to pay taxes)
  8. 4 Shares withheld for taxes Director gave up 1,465 shares (to pay taxes)
  9. 4 Shares withheld for taxes Director gave up 1,465 shares (to pay taxes)
  10. 4 Shares withheld for taxes Director gave up 1,465 shares (to pay taxes)
  11. 4 Shares withheld for taxes Director gave up 1,465 shares (to pay taxes)
  12. 4 Shares withheld for taxes Director gave up 1,465 shares (to pay taxes)
  13. 4 Shares withheld for taxes Director gave up 3,175 shares (to pay taxes)
  14. 4 Shares withheld for taxes Director gave up 1,465 shares (to pay taxes)
  15. 4 Shares withheld for taxes Director gave up 930 shares (to pay taxes)
  16. 4 Shares withheld for taxes Director gave up 793 shares (to pay taxes)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 67 · 1,323 filings